AXELERA-AI
15.12.2022 12:21:36 CET | Business Wire | Press release
European artificial intelligence (AI) startup Axelera AI announced today its Metis AI Platform, encompassing the MetisTM AI Processing Unit (AIPU) chip and the VoyagerTM SDK software stack – available as cards, boards, and vision systems – to accelerate computer vision processing at the edge.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221213005651/en/
About the Axelera AI Metis AI platform. (Graphic: Business Wire)
The Metis AI Platform redefines affordability for Edge AI solutions without compromising on performance and is the first product in the market to offer hundreds of TeraOPS (TOPs) compute performance at an edge price-point. The products will be available in different form factors: an Edge M.2 acceleration card, offering up to 214 TOPs priced from $149, corresponding to only $0.70 per TOPs, as well as a PCIe card delivering up to 856 TOPs, powered by four Metis AIPUs. Separately, Axelera AI is working with partners to develop system ready solutions.
Axelera’s Metis AIPU delivers an unprecedented peak performance of 214 TOPs with an energy efficiency of 15 TOPs/W at INT8, thanks to a novel Digital In-Memory Computing (D-IMC) engine. FP32 iso-accuracy is achieved without the need to retrain the neural network models.
The software stack, Voyager SDK, includes an integrated compiler, a runtime stack and powerful optimization tools that enable customers to import their own models delivering class-leading performance on the Metis AI platform. Application templates speed up development, with customers able to choose from Axelera’s carefully curated Model Zoo.
Axelera AI opens the Early Access Program a unique collaboration opportunity for leading companies to co-design real-world Edge AI solutions based on the Metis AI platform. The Metis AI platform will be available for selected customers in early 2023. For more information, visit www.axelera.ai.
About Axelera AI
Axelera AI is designing the world’s most powerful and advanced solutions for AI at the edge. Its game-changing MetisTM AI platform – a holistic hardware and software solution for AI interference at the edge – enables computer vision applications to become more accessible, powerful and user friendly than ever before. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, Italy and the UK, with 100 employees in 11 countries. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies. Visit the Axelera AI website for more information.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221213005651/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences12.3.2026 14:00:00 CET | Press release
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Enodia has acquired Kezar’s assets from its Sec61-based discovery and development program. The acquisition enables Enodia to advance its understanding of Sec61 selectivity mechanisms, expanding biological and translational insights for faster progression toward key clinical milestones. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312627573/en/ Under the terms of the purchase agreement between Enodia and Kezar, Kezar w
Adtran to showcase industry-leading open optical networking for the AI era at OFC 202612.3.2026 14:00:00 CET | Press release
News summary: Adtran will show how intelligent optical networks can scale infrastructure while controlling power, complexity and security risks Highlights include LiteWave800™, an ultra‑low‑power 800G pluggable transceiver, which sets a new 1pJ/bit benchmark for intra‑data center connectivity Adtran will participate in OIF multi‑vendor interoperability demos and present European‑led innovation through advanced research projects Adtran today announced that it will showcase its latest optical innovations at OFC 2026, taking place from March 15 to 19 in Los Angeles. The company will outline how intelligent, secure and power‑efficient optical networks are shaping the next phase of AI infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311958018/en/ Adtran’s optical networking technology is helping build the foundation for the AI era. At Adtran’s booth (1001), visitors can explore solutions spanning ultra‑low‑power
Wellesley Hills Financial Goes Global: New London and New York Hubs Signal Aggressive Expansion into Transatlantic Fintech M&A12.3.2026 13:00:00 CET | Press release
With the addition of industry veterans Barry Davis and Bill Shraga, WHF strengthens its cross-border capabilities and scales its specialized Merchant Portfolios platform to a national level. Wellesley Hills Financial (“WHF”), a premier fintech and payments-focused investment bank spanning the lower to upper middle market, today announced a series of senior appointments and geographic expansions that further scale its global advisory platform and deepens its capabilities across the payments and fintech ecosystems. The firm has appointed Barry Davis as Executive Advisor, based in London, added Managing Director Bill Shraga in New York, and expanded its payments consulting subsidiary, Merchant Portfolios (“MP”), with the addition of EVPs Lance McCord in North Carolina and Nolan Pittman in Arizona. Strengthening Transatlantic Connectivity Barry Davis joins WHF as the firm’s first London-based Executive Advisor, marking a significant milestone in WHF’s international expansion. His appointme
Prodalim Strengthens its Functional Platform to Enter the Fast-Growing Nutraceutical Market with the Acquisition of Sylvestre, a Market Leader in Botanical Extracts Based in Brazil12.3.2026 11:45:00 CET | Press release
The acquisition positions Prodalim to deepen its fast-growing functional beverage solutions offering, accelerate its expansion into the US functional ingredients market, and broaden its presence across emerging markets Prodalim, a global leader in juice and specialty ingredients solutions, announced today the acquisition of Sylvestre, a leading Brazilian producer of botanicals and functional extracts addressing the nutraceutical market. Sylvestre’s existing owners and management team will remain with the company and support its integration into Prodalim’s platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312584318/en/ Founded in 1992 in Brazil, Sylvestre is a trusted supplier of high-quality natural ingredients, specializing in botanical extracts, fruit powders, superfruits, teas, and unique functional plant-based solutions sourced from the rich and diverse Brazilian flora. With a portfolio of more than 200 natural
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 202612.3.2026 11:30:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Stifel 2026 Virtual CNS Forum, from March 17-18, 2026, and will participate in a fireside chat on March 18, 2026, at 10:30am ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom